Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6402678 | 0.71 | MEN1 (0.36) | — | |
| SCHEMBL2482028 | 0.70 | MEN1 (0.32) | — | |
| SCHEMBL4559147 | 0.63 | MEN1 (0.41) | — | |
| SCHEMBL14984285 | 0.62 | ABCB1 (0.31) | — | |
| SCHEMBL5625132 | 0.61 | CYP19A1 (0.33) | CYP19A1 | |
| SCHEMBL9243218 | 0.61 | MEN1 (0.32) | CYP19A1 | |
| SCHEMBL9243213 | 0.61 | MEN1 (0.32) | CYP19A1 | |
| SCHEMBL23670846 | 0.61 | — | — | |
| SCHEMBL23670850 | 0.61 | — | — | |
| SCHEMBL23670849 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7160852-B2 | Polyalklbicylic derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC (US) | 2007-01-09 | — | — | US | claimed |
| EP-1262481-B1 | Indanone derivatives for use as fragrances | INT FLAVORS & FRAGRANCES INC (US) | 2004-10-06 | — | — | EP | claimed |
| US-7160852-B2 | Polyalklbicylic derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC (US) | 2007-01-09 | — | — | US | disclosed |
| EP-1262481-B1 | Indanone derivatives for use as fragrances | INT FLAVORS & FRAGRANCES INC (US) | 2004-10-06 | — | — | EP | disclosed |
| US-20040029769-A1 | Polyalklbicylic derivatives | LEVORSE ANTHONY T (US) | 2004-02-12 | — | — | US | disclosed |
| US-6632788-B2 | For use as fragrance chemicals | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2003-10-14 | — | — | US | disclosed |
| US-20030004090-A1 | Polyalkylbicylic derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2003-01-02 | — | — | US | disclosed |
| EP-1262481-A1 | Indanone derivatives for use as fragrances | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2002-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029769-A1 | Polyalklbicylic derivatives | CUTA, OR51E2, COL14A1 | CYP19A1 2573/4885 |
| US-20030004090-A1 | Polyalkylbicylic derivatives | COL1A1, TAS1R1, CUTA | CYP19A1 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.